Volume 11, Number 7—July 2005
Research
Survey of Tickborne Infections in Denmark
Sigurdur Skarphédinsson*
, Per M. Jensen†, and Kåre Kristiansen‡
, Per M. Jensen†, and Kåre Kristiansen‡
Table 2
Regional distribution of Borrelia-, Anaplasma phagocytophilum–, and tickborne encephalitis (TBE)-complex virus–positive roe deer*
| Region + state forest district | n | % Borrelia positive† | % A. phagocytophilum positive* | % A. phagocytophilum PCR positive | % TBE-complex virus HI-test positive |
|---|---|---|---|---|---|
| Jutland | |||||
| Åbenrå | 14 | 21.4 | 100 | 21.4 | 14.3 |
| Buderupholm | 7 | 71.4 | 100 | 30.0 | 0 |
| Feldborg | 7 | 25.0 (n = 4) | 80.0 (n = 5) | 14.3 | 0 |
| Fussingø | 2 | 0 | 50.0 | 50.0 | 0 |
| Gråsten | 10 | 50.0 | 88.8 (n = 9) | 50.0 | 10 |
| Haderslev | 26 | 16.0 (n = 25) | 91.7 (n = 24) | 61.5 | 16.0 |
| Lindet | 8 | 25.0 | 100 | 50.0 | 12.5 |
| Oxbøl | 13 | 46.2 | 100 | 53.8 | 0 |
| Palsgård | 15 | 9.1 (n = 11) | 90.9 (n = 11) | 20.0 | 9.1 |
| Randbøl | 12 | 16.7 | 100 | 8.3 | 8.3 |
| Silkeborg | 5 | 60.0 | 100 | 80.0 | 20.0 |
| Thy | 5 | 0 | 80.0 | 20.0 | 0 |
| Ulborg | 2 | 0 | 100 | 50.0 | 0 |
| Funen | |||||
| Fyn | 12 | 41.7 | 100 | 50.0 | 0 |
| Zealand-Lolland-Falster | |||||
| Falster | 17 | 46.7 (n = 15) | 100 (n = 16) | 41.2 | 6.3 |
| Frederiksborg | 17 | 52.9 | 88.2 | 52..9 | 5.8 |
| Jægersborg | 8 | 50.0 | 100 | 25.0 | 12.5 |
| Kronborg | 9 | 55.6 | 100 | 66.6 | 0 |
| København | 15 | 40.0 | 100 | 46.6 | 0 |
| Odsherred | 5 | 80.0 | 100 | 80.0 | 0 |
| Tisvilde | 7 | 42.9 | 85.7 | 14.3 | 0 |
| Bornholm | 19 | 36.8 | 100 | 46.2 | 31.6 |
| Region unknown | 2 | ||||
*PCR, polymerase chain reaction; HI, hemagglutination inhibition.
†Because the amount of material received from some state forest districts was limited, not all samples were available for Borrelia and Anaplasma serologic testing. Where not all samples were tested, n is indicated in parentheses.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.